• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURAVI LTD. EMBOTRAP III 5 MM X 37 MM; EMBOTRAP III REVASCULARIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURAVI LTD. EMBOTRAP III 5 MM X 37 MM; EMBOTRAP III REVASCULARIZATION DEVICE Back to Search Results
Model Number ET309537
Device Problem Difficult to Remove (1528)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/06/2021
Event Type  malfunction  
Manufacturer Narrative
Product complaint # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Lot ¿ not reported.Initial reporter: the customer contact information, including name, occupation, phone, fax, and e-mail address, was not reported.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
As reported by the field, during a mechanical thrombectomy, an embotrap iii 5 mm x 37 mm (et309537, lot unknown) was used to remove thrombus at the posterior cerebral artery (pca).The embotrap was fully deployed to remove thrombus around the ba-top.However, the physician felt a little resistance when the embotrap was being retracted.There was no bleeding after the procedure or patient injury.It was unclear if continuous flush was done.
 
Manufacturer Narrative
Product complaint (b)(4) a review of the dhr records confirms that there were no issues with the assembly of the lot (sub and top assembly), all rejects were accounted for during the dhr review.There were no issues with sterilisation and the final number of units released reconciles with the number of units released by advant medical to cerenovus.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Manufacturer Narrative
Product complaint # (b)(4).Section b5: additional information received indicated that the resistance was confirmed at the beginning of the procedure, therefore, probably there was no thrombus in the device.The withdrawal was performed as per the instructions for use (ifu).The withdrawal difficulty was encountered shortly after the stent was removed.The device was re-sheathed a little inside the microcatheter and resistance decreased.It was removed from the patient.It was not necessary to remove concomitant devices with the complaint device.One pass was made to attempt to retrieve the clot.The clot consistency was a ¿little firm¿.A syringe was used for aspiration.There was no severe tortuosity.Section e1.Initial reporter phone: (b)(6).A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Complaint conclusion: as reported by the field, during a mechanical thrombectomy, an embotrap iii 5 mm x 37 mm (et309537, 21f103av) was used to remove thrombus at the posterior cerebral artery (pca).The embotrap was fully deployed to remove thrombus around the ba-top.However, the physician felt a little resistance when the embotrap was being retracted.There was no bleeding after the procedure or patient injury.It was unclear if a continuous flush was done.Additional information received indicated that the resistance was confirmed at the beginning of the procedure, therefore, probably there was no thrombus in the device.The withdrawal was performed as per the instructions for use (ifu).The withdrawal difficulty was encountered shortly after the stent was removed.The device was re-sheathed a little inside the microcatheter and resistance decreased.It was removed from the patient.It was not necessary to remove concomitant devices with the complaint device.One pass was made to attempt to retrieve the clot.The clot consistency was a ¿little firm¿.A syringe was used for aspiration.There was no severe tortuosity.The device was discarded, therefore, no further investigation can be performed.A review of the device history record associated with lot number 21f103av presented no issues during the manufacturing or inspection process that can be related to the reported event.Withdrawal difficulty from vessel is a potential complication associated with the use of the embotrap iii revascularization device in endovascular mechanical thrombectomy.The embotrap instructions for use (ifu) warns the user to never withdraw the device against significant resistance.Assess the cause of resistance using fluoroscopy and if necessary, advance the microcatheter over the device to resheath or partially resheath to aid withdrawal.With the amount of information available and without the device for analysis, it is not possible to draw a conclusion between the device and the reported event.However, there are clinical, procedural factors, including vessel characteristics, tortuosity, clot burden/characteristics, device interaction, device selection, and operator technique that may have contributed to the event.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOTRAP III 5 MM X 37 MM
Type of Device
EMBOTRAP III REVASCULARIZATION DEVICE
Manufacturer (Section D)
NEURAVI LTD.
block 3 ballybritt
business park
galway H91 K 5YD
EI  H91 K5YD
Manufacturer (Section G)
ADVANT MEDICAL
parkmore business park west
galway H91 P V0V
EI   H91 PV0V
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key12827624
MDR Text Key282989792
Report Number3011370111-2021-00146
Device Sequence Number1
Product Code NRY
UDI-Device Identifier10886704084570
UDI-Public10886704084570
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K193063
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberET309537
Device Catalogue NumberET309537
Device Lot Number21F103AV
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/14/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-